Stockreport

IBN Coverage: Clene (NASDAQ: CLNN) CEO Discusses CNM-Au8(R) Trial Results on BioMedWire Podcast [Yahoo! Finance]

Clene Inc.  (CLNN) 
PDF LOS ANGELES, CA - ( NewMediaWire ) - August 29, 2024 - Clene (NASDAQ: CLNN) , a late clinical-stage biopharmaceutical company focused on improving mitochondrial health [Read more]